Case Study

Averaging 170% Enrollment Across Three Type 1 Diabetes Sites

Across three Texas sites, Tekton delivered consistent enrollment and regulatory performance for a Type 1 diabetes trial. All three sites exceeded their targets. Physician-led database review and detailed prescreening helped the McKinney site move quickly while focusing outreach on participants likely to meet the study requirements.

  • All three sites exceeded enrollment targets
  • 170% average enrollment across three sites
  • 1-day average regulatory turnaround across three sites
  • McKinney enrolled more than 200% of its initial goal and moved from activation to first participant visit in 4 days

senior-patient-consultation

About This Study

CLIENT
Large pharmaceutical company
TRIAL
Type 1 diabetes
TEKTON COVERAGE
Three sites in Irving, McKinney, and San Antonio, TX

Partner With Tekton

Send us a synopsis or your I/E criteria. We'll respond with the Tekton sites and investigators we recommend, as well as site-level enrollment forecasts.

Complete the form on this page or email .

Submit Your Information